戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 at is observed in TLE and may be potentially neuroprotective.
2 suggesting that modulating glycolysis may be neuroprotective.
3 ble disease-associated niche, where they are neuroprotective.
4  an increase in mitophagy that is ultimately neuroprotective.
5 ctor (CDNF) is expressed in the brain and is neuroprotective.
6 ransport is disrupted and its restoration is neuroprotective.
7 roke that GPR35 activation by pamoic acid is neuroprotective.
8 ide genetic evidence that Drp1 inhibition is neuroprotective.
9 d neuronal death, whereas ISR activation was neuroprotective.
10 T1-PGC-1alpha axis, which is relevant to the neuroprotective action of 5-HT.
11 ate the mitochondrial effects of 5-HT in its neuroprotective action.
12 10-1), which displayed anti-inflammatory and neuroprotective actions in rodent models of status epile
13 ipheral or brain FNDC5/irisin attenuates the neuroprotective actions of physical exercise on synaptic
14 the hippocampus, a key signaling mediator of neuroprotective actions.
15 inal cleavage fragment, N1, has demonstrated neuroprotective activities in vitro and in vivo.
16 es of these compounds, including potentially neuroprotective activities.
17 superfamily has angiogenic, neurotrophic and neuroprotective activities.
18        Previously, we characterized a potent neuroprotective activity mediated by retinal astrocyte c
19                                              Neuroprotective activity of parkin has been linked to it
20 ermine a structure-activity relationship for neuroprotective activity.
21 g of Abeta into dense plaque is an important neuroprotective activity.SIGNIFICANCE STATEMENT Genetic
22 evidence that microglial debris clearance is neuroprotective after brain injury in vivo.
23 e findings suggest that neuron-derived E2 is neuroprotective after ischemic brain injury via a mechan
24 netrant when administered intraperitoneally, neuroprotective against Abeta toxicity and restore dimin
25 t synthesis enables gram-scale access to the neuroprotective agent (+/-)-indanostatin.
26   These findings extend the role of ANG as a neuroprotective agent and underscore its potential utili
27     L-Carnosine has shown great promise as a neuroprotective agent in experimental stroke, but transl
28  In vivo efficacy of 15 makes it a promising neuroprotective agent in oxidative stress-related diseas
29 ocampal neurons, and that treatment with the neuroprotective agent P7C3-A20 eradicates persistent rem
30 nimine oxide (23) was shown as a very potent neuroprotective agent.
31 spheres (MSs) incorporating three recognised neuroprotective agents (dexamethasone (DX), melatonin (M
32 , the topical administration of the selected neuroprotective agents appears useful in preventing the
33 3-Arylcoumarins have already been studied as neuroprotective agents by our group.
34 for the identification and implementation of neuroprotective agents could provide novel therapeutics
35                                Currently, no neuroprotective agents have been shown to impact the cli
36                                   The use of neuroprotective agents in stroke has been a notable fail
37                                 Furthermore, neuroprotective agents, including fenofibrate and simvas
38 elected four compounds to study as potential neuroprotective agents.
39 ic-induced Parkinsonism and the discovery of neuroprotective agents.
40 nds leading to development of more effective neuroprotective agents.
41 ocal injury antagonist distinguished for its neuroprotective, analgesic, and anti-inflammatory proper
42 tribute a significant portion to the in vivo neuroprotective and anti-aging effects of Rap via an aug
43 ive esters have shown significant promise as neuroprotective and anti-inflammatory agents to treat ch
44 e driven by interleukin 10 (IL-10), a potent neuroprotective and anti-inflammatory cytokine.
45                          Here, we tested the neuroprotective and anti-inflammatory effects of cromoly
46 of hiPSC-MGE cells after SE mediated several neuroprotective and antiepileptogenic effects in the hos
47     The results demonstrate that IRL-1620 is neuroprotective and attenuates neural damage following c
48  at the level of phosphorylated eIF2alpha is neuroprotective and avoids the pancreatic toxicity cause
49 stem cell (MSC) therapy has been shown to be neuroprotective and can induce neuroregeneration in stro
50 cetylase (HDAC) inhibitors are known to have neuroprotective and cognition-enhancing properties, but
51 that neuron-derived 17beta-estradiol (E2) is neuroprotective and critical for induction of reactive a
52 s assessed by a set of in vitro antioxidant, neuroprotective and cytotoxic assays.
53 ght profitably be used in clinical trials of neuroprotective and disease-modifying treatments, improv
54 hat isoform-D is also expressed selectively, neuroprotective and downregulated in HD mice and patient
55 eading to simplified derivatives with potent neuroprotective and immunosuppressive activity.
56 active protein 1 (MCP1) has been shown to be neuroprotective and is released by astrocytes.
57 previous reports where miR-23a functioned in neuroprotective and muscle atrophy-antagonizing roles.
58 K3 inhibition, and specifically VP3.15, as a neuroprotective and neuroreparative disease-modifying tr
59 n administration of recombinant netrin-1 are neuroprotective and neurorestorative in mouse and rat mo
60 rofilament levels were decreased, indicating neuroprotective and neurorestorative processes.
61                 General anesthetics are both neuroprotective and neurotoxic with unclear mechanisms.
62 ammalian brain can be manipulated to adopt a neuroprotective and pro-regenerative phenotype that can
63  therapeutic potential for PD, offering both neuroprotective and symptomatic improvement.
64 ys downstream of TrkB mediate the desirable (neuroprotective) and undesirable (epileptogenesis) conse
65 rine protease APC, exerts vasculoprotective, neuroprotective, and anti-inflammatory activities in rod
66  antihypertensive, antihypercholesterolemic, neuroprotective, antiobese properties and promote gut he
67 ge and Abeta production, while up-regulating neuroprotective APP-alpha-cleavage.
68                  We tested three independent neuroprotective approaches-normobaric hyperoxia, the fre
69 body was able to reverse the diminishment in neuroprotective astrocyte reactivity, and attenuate neur
70  discussed with a focus on the translational neuroprotective benefits including their mechanistic bas
71 B-Shc-Akt signaling and thereby preserve the neuroprotective benefits.SIGNIFICANCE STATEMENT Temporal
72         We describe herein the synthesis and neuroprotective capacity of an array of 31 compounds com
73 d species supported and confirmed its strong neuroprotective capacity.
74 e novel carriers have the ability to deliver neuroprotective cargo effectively to the brain.
75 drive tertiary contact in PrP(C), inducing a neuroprotective cis interaction that structurally links
76 ular signaling pathways mediating retrograde neuroprotective communication.
77 early in Parkinson's disease could reflect a neuroprotective compensatory mechanisms and pro-inflamma
78 d not alter the content of picolinic acid, a neuroprotective compound, in red wine.
79 maximum production rate of kynurenic acid, a neuroprotective compound.
80 acker (MWT), and tested whether 38 candidate neuroprotective compounds could improve the mobility of
81 ation for the development of highly specific neuroprotective compounds for the treatment of neurologi
82 ive astrocytes shed EVs containing a host of neuroprotective compounds, which include fibroblast grow
83  TrkB-Shc-Akt signaling pathway mediates the neuroprotective consequences of TrkB activation followin
84                                              Neuroprotective disruptions of the E3 ubiquitin ligase h
85 ss whether the topical administration of two neuroprotective drugs (brimonidine and somatostatin) cou
86 nical and clinical research identified three neuroprotective drugs acting on different axonal pathobi
87 herapeutic candidates for the development of neuroprotective drugs against AD.
88 orting evidence, Chinese herbal products and neuroprotective drugs are widely used, and the increased
89 g, and cognition-enhancing protein Klotho is neuroprotective due to its anti-inflammatory, antioxidat
90 tudies showed that endogenous estrogens have neuroprotective effect against oxidative damage.
91 nic activity, is found to have the strongest neuroprotective effect against oxidative neurotoxicity a
92  A major technical hurdle in determining any neuroprotective effect by DBS is its use in mid- to late
93 dose erythropoietin has been shown to have a neuroprotective effect in preclinical models of neonatal
94 onnectivity analyses crucially supported the neuroprotective effect of bilingualism by showing an inc
95 in the whole population, we did not find any neuroprotective effect of brimonidine or somatostatin.
96 er hypoxia-ischaemia; however, the potential neuroprotective effect of facilitated passive cooling is
97                                          The neuroprotective effect of GPR35 activation depends on pr
98                           We then tested the neuroprotective effect of neuregulin-1 (NRG-1) against h
99                                              Neuroprotective effect of placenta-derived mesenchymal s
100                        Here, we assessed the neuroprotective effect of topical eye delivery of the p3
101 HT induction, DMQ-MSs showed a significantly neuroprotective effect on RGCs compared to OHT only cont
102  both PFC and VTA DAergic activity states, a neuroprotective effect that persists into adulthood.
103                                         Such neuroprotective effect was obtained using the recombinan
104 zes with alphaS, has been shown to provide a neuroprotective effect, but the molecular mechanism by w
105 ith anti-galectin 1 antibody decreased their neuroprotective effect, suggesting that PMSC exosomes li
106 h the prediction that C1q reduction exerts a neuroprotective effect.
107                                 However, the neuroprotective effector proteins induced by RBM3 and th
108 cid (DHA) has been shown to have significant neuroprotective effects after hemisection and compressio
109                                 It displayed neuroprotective effects against oxygen-glucose deprivati
110 ivity, demonstrating powerful and functional neuroprotective effects against THC-induced developmenta
111 lypyrrolidone (PVPP) winery residue, and its neuroprotective effects and ability to modulate the kine
112 sults demonstrate that chrysophanol provided neuroprotective effects and inhibited glial activation,
113        We demonstrate that the TBK1-mediated neuroprotective effects are due to phosphorylation-depen
114 eting HIPK2 and its kinase activity can have neuroprotective effects by elevating Parkin protein leve
115   A lack of convulsant activity coupled with neuroprotective effects have led some to postulate an al
116           Prompted by the discovery that NAS neuroprotective effects in EAE are abrogated in mice lac
117 lyn sodium, an FDA approved compound, exerts neuroprotective effects in mouse models of Alzheimer's d
118 t in stroke, with Ang-(1-7) reported to have neuroprotective effects in pre-clinical stroke models.
119 determined that two of these compounds exert neuroprotective effects in the nanomolar concentration r
120 ERM raloxifene has structural and functional neuroprotective effects in the retina.
121 human retinal degeneration due to its potent neuroprotective effects in various animal models.
122 the goal of this work was to better test the neuroprotective effects of a formulation of micronized P
123 rk uncovers molecular networks which mediate neuroprotective effects of Emapunil, including microglia
124                We recently reported that the neuroprotective effects of fingolimod in 5xFAD transgeni
125 rain through carbogen breathing reversed the neuroprotective effects of FLASH, while radiochemical st
126 obiota with antibiotics partly abolishes the neuroprotective effects of IF.
127 rther demonstrating functional and long-term neuroprotective effects of l-theanine in the mesocortico
128                   Purpose To investigate the neuroprotective effects of low-intensity pulsed (LIP) ul
129 ecreased cellular survival without affecting neuroprotective effects of melatonin.
130                                          The neuroprotective effects of micronized PEA (PEA-m) formul
131 ce of multiple molecular contributors to the neuroprotective effects of NAPE-PLD deletion, including
132                        Here, we explored the neuroprotective effects of pharmacologically activating
133 press the human Abeta42 peptide to assay the neuroprotective effects of PI3K in adult Drosophila mela
134 onal imaging endpoints, aimed to examine the neuroprotective effects of RIC in ischemic stroke model.
135 t for additional evaluation of the potential neuroprotective effects of senolytics on glaucoma and ot
136         Depletion of microglia abolishes the neuroprotective effects of sTREM2.
137 results suggest that topical rh-NGF exhibits neuroprotective effects on retinal neurons via influenci
138                              Their potential neuroprotective effects were examined in mouse focal isc
139 NPs) were designed and synthesized and their neuroprotective effects were measured using in vitro and
140 encapsulating carnosine exhibited remarkable neuroprotective effects with a dose of carnosine 3 order
141 d less inflammatory phenotypes and may exert neuroprotective effects.
142 nsitization) implies that agonists may exert neuroprotective effects.
143 ediated neutralization of pHERV-W ENV exerts neuroprotective effects.
144 79 e4 carriers in order to examine potential neuroprotective effects.
145 -OXA) possesses anti-inflammatory and potent neuroprotective effects.
146 ntibacterial, antifungal, antiparasitic, and neuroprotective effects.
147 ggests that chronic gamma entrainment offers neuroprotective effects.
148  the target calcium channels associated with neuroprotective effects.
149                                          The neuroprotective efficacy of hydroxyurea (HU) remains unc
150 pment can be modulated extrinsically by both neuroprotective (environmental enrichment) and detriment
151 pment can be modulated extrinsically by both neuroprotective (environmental enrichment) and detriment
152 ly mediates immune surveillance and is often neuroprotective, excessive engagement of the system can
153 ion of Cdk5/p25 hyperactivation in vivo is a neuroprotective factor during ALS pathogenesis by crossi
154 riptional regulatory network mediated by the neuroprotective factor Hif2a as underlying neural circui
155 e adenine dinucleotide (NAD(+)) synthase and neuroprotective factor, significantly mitigates mutant H
156 ly, but also clinically as immunomodulatory, neuroprotective factors for treating trauma or disease i
157 tate, improving synaptic function, enhancing neuroprotective factors, and reducing DNA damage in neur
158 e to sequester the toxic species acting in a neuroprotective fashion.
159 ls (15-30mg/l) were achieved at 2 h and were neuroprotective following HI, but ethanol vehicle was pa
160 f mothers with HIV during pregnancy might be neuroprotective for the child, and when continued post p
161                                PMSCs exhibit neuroprotective function by increasing cell number and n
162 ic efficiency is potentially involved in the neuroprotective function of DJ-1 as well as its role in
163                  Our study thus identifies a neuroprotective function of microglia in the clearance o
164 ur results provide evidence of the autocrine neuroprotective function of VEGF on RGCs is crucially in
165 eloped an EPO-R76E derivative that maintains neuroprotective function without effects on hematocrit,
166 se in neurites, suggesting that they exhibit neuroprotective function.
167 on by Mdm2 could be targeted to increase its neuroprotective functions, which has implications for an
168 se to inflammation to mediate a compensatory neuroprotective gene expression program that desensitize
169 ral-mediated, genome-wide screen to identify neuroprotective genes in wild-type and Huntington's dise
170  nitric oxide synthetase (NOS1 and NOS3) and neuroprotective genes with downregulation of proinflamma
171        We focused on APOE e2, an established neuroprotective genetic variant against Alzheimer's dise
172 ck after AMI randomized in the Neuroprotect (Neuroprotective Goal Directed Hemodynamic Optimization i
173                        We propose a model of neuroprotective homeostatic plasticity, extending organi
174 P1 disinhibition on mTORC1 repression may be neuroprotective; however, whether 4E-BP1 overexpression
175        In vitro studies showed DMQ-MSs to be neuroprotective in a glutamate-induced cytotoxicity mode
176 ody (KB) produced in ketogenic diet (KD), is neuroprotective in aralar-knock-out (KO) neurons and mic
177 n repair and suggest that oral GlcNAc may be neuroprotective in demyelinating diseases like MS.
178 e; however, whether 4E-BP1 overexpression is neuroprotective in mammalian neurons is yet to be fully
179 tudies have shown that intranasal insulin is neuroprotective in models of Alzheimer's disease, Parkin
180                           LTCC blockers were neuroprotective in mouse neurotoxin models of PD, and is
181            Inhibition of miR-142-3p could be neuroprotective in MS.
182          Disrupted CX3CR1-CCR2 signaling was neuroprotective in part by attenuating monocyte and neut
183 organ injury in other disease states and are neuroprotective in preclinical models of critical illnes
184 CK (Rho kinase) pathway has been shown to be neuroprotective in SOD1(G93A) mice, the most commonly us
185 ertain strains of T. gondii infection can be neuroprotective in the context of a secondary insult lik
186 r cobalamin, a vitamin B12 vitamer, would be neuroprotective in vitro and in vivo.
187                   Decreased Tet2 activity is neuroprotective, in vivo, and may be a new therapeutic t
188 f 5'-AMP-activated protein kinase (AMPK) and neuroprotective induction of autophagy, implicating the
189 ly neurotoxic quinolinic acid instead of the neuroprotective kynurenic acid in mood disorders but not
190 s pathway, thereby demonstrating a potential neuroprotective mechanism involving SORLA.
191                     We demonstrated that the neuroprotective mechanism of the investigated PPZ is bas
192 of how cholesterol metabolism can modulate a neuroprotective mechanism that attenuates alpha-synuclei
193 LC-derived norepinephrine (NE) can stimulate neuroprotective mechanisms and modulate immune cells, wh
194  related to neurodegenerative phenotypes and neuroprotective mechanisms of the small-molecule ISRIB d
195 eractions promote viral clearance via mainly neuroprotective mechanisms, they may also promote neurop
196 tome may provide valuable insight into these neuroprotective mechanisms.
197 y in biosynthetic pathways of prohomeostatic/neuroprotective mediators neuroprotectin D1 (NPD1) and e
198 r LPS delivered systemically can also induce neuroprotective microglia in the spinal cord.
199 rmacologic or genetic approaches can yield a neuroprotective microglial phenotype that profoundly aid
200 in, without affecting the release of healthy neuroprotective mitochondria.
201 al disorders, and there is an unmet need for neuroprotective modalities to improve photoreceptor surv
202       Stimulated astrocytes secrete EVs with neuroprotective molecules including heat shock proteins,
203 und that inhibits alphaSyn misfolding and is neuroprotective, multiple compounds that restore phagocy
204  recovery and quality, and the fact that the neuroprotective olfactory ensheathing cell (OEC) subset
205 l phagocytosis after brain injury in vivo is neuroprotective or neurotoxic is not known.
206  discuss the evidence for the neurotoxic and neuroprotective pathways that have been attributed to mi
207                                    In brain, neuroprotective pathways were identified as potential ta
208                                          The neuroprotective potential of astrocytes was itself sensi
209 t that CK2 inhibitors could release the full neuroprotective potential of HSJ1, and deserve future in
210 aim of the current study was to evaluate the neuroprotective potential of mesenchymal stem cells (MSC
211                                 Finally, the neuroprotective potential of optogenetic collicular stim
212 hium, a well-known mood stabilizer, has both neuroprotective, pro-neurogenic as well as antitumor eff
213 r the development of treatments that augment neuroprotective processes while limiting ongoing immunop
214 onded to luminal infection by upregulating a neuroprotective program via beta(2)-adrenergic receptor
215 we go on to demonstrate that hydralazine has neuroprotective properties against endogenous and exogen
216 eristics of an immature neutrophil, that had neuroprotective properties and drove CNS axon regenerati
217                          The inhibitors show neuroprotective properties in a murine hippocampal cell
218  global neurocognition, it may have specific neuroprotective properties in attention/vigilance, parti
219 o possess antioxidant, antiinflammatory, and neuroprotective properties in experimental autoimmune en
220 SPO ligands have shown anti-inflammatory and neuroprotective properties in models of CNS injury.
221 DM1 myoblasts, while compounds 1 and 53 have neuroprotective properties in SMA-derived cells.
222   Although recent studies have explained the neuroprotective properties of PEA-OXA, nothing is known
223 d astrocytes promote synaptogenesis, exhibit neuroprotective properties, display calcium transients i
224 imental work shows that heparinoids may have neuroprotective properties.
225 ate in various neural regions and to possess neuroprotective properties.
226 (ID) causing mutations is activity-dependent neuroprotective protein (ADNP), with intact ADNP protect
227 is caused by mutations in activity-dependent neuroprotective protein (ADNP).
228 an active fragment of the activity-dependent neuroprotective protein (ADNP).
229 tein-alpha (sAPPalpha) is a neurotrophic and neuroprotective protein that can promote synaptic plasti
230 njury after alkali burn and explored a novel neuroprotective regimen suitable for prompt administrati
231 rontotemporal dementia mice, both drugs were neuroprotective, rescued memory deficits and reduced hip
232 ogens to achieve a therapeutically effective neuroprotective response against ISCI.
233 herent variability and sex-dependence of the neuroprotective response to HT, with the majority of stu
234  Muller survival pathways might underlie the neuroprotective response.
235 of sporadic ALS and uncovers both an initial neuroprotective role for astrocytes and the cell type-sp
236                          Herein, we report a neuroprotective role for microglia in the clearance of n
237 es mitigates inflammation, consistent with a neuroprotective role for Shh signaling after injury.
238 ere, we argue that microglia play an overall neuroprotective role in prion pathogenesis.
239 n striatal and cortical neurons that plays a neuroprotective role in these cells.
240 idered to have a safer profile; however, its neuroprotective role in vivo is not known.The goal of th
241 aper, Gratuze et al. demonstrated a putative neuroprotective role of a key Alzheimer risk variant, TR
242 eration of neural progenitors, arguing for a neuroprotective role of adiponectin.
243 ulting in neuroinflammation, which turns the neuroprotective role of microglia detrimental as charact
244          Altogether, these findings validate neuroprotective role of Shh signaling and highlight the
245  Evidences have suggested a neurotrophic and neuroprotective role of VEGF, albeit in retina, cellular
246 lly, ROS scavenging by antioxidants played a neuroprotective role via increasing HIF-1alpha expressio
247 unction, recent data suggest that they exert neuroprotective roles in CNS homeostasis through continu
248 ndent sensitizing influences such as loss of neuroprotective S1P are more important drivers of neurod
249 s Ly-6C(Lo) monocytes/macrophages to relay a neuroprotective signal into the ischemic brain.
250 dentified a prominent lipid component of the neuroprotective signal through metabolomics screening.
251 s, we identified a novel non-cell autonomous neuroprotective signaling cascade mediated through PI3K
252 hate (S1P) is a potent vasculoprotective and neuroprotective signaling lipid, synthesized primarily b
253 ameter) to assess penetration of a candidate neuroprotective siRNA.
254 TATEMENT Data in this report indicate that a neuroprotective spinal cord microglia response can be tr
255 spiratory support, and potentially employing neuroprotective strategies (eg, targeted temperature man
256 f mutant Htt aggregates remains limited, and neuroprotective strategies combating mutant Htt-induced
257 osis (MS) research, there is still a lack of neuroprotective strategies, because the main focus has r
258 urotoxicity and the development of effective neuroprotective strategies.
259 ations and may enable discovery of selective neuroprotective strategies.
260 euro-axonal injury, is paramount to optimize neuroprotective strategy in MS.
261 at targeting CSF1R signaling may be a viable neuroprotective strategy in PD that disrupts pro-inflamm
262 via PKM2-to-PKM1 substitution is a promising neuroprotective strategy.
263 chemic event, there is resurgent interest in neuroprotective stroke therapies.
264                                  Given these neuroprotective studies, we hypothesized that a prolonge
265 ormal tau indicates the presence of inherent neuroprotective systems in brain.
266                           To identify such a neuroprotective target, we conducted a set of complement
267  receptors have been implicated as potential neuroprotective targets for glaucoma.
268 ical Drp1 inhibition has been put forward as neuroprotective, the specificity and mechanism of the in
269  treatment has the potential to be used as a neuroprotective therapeutic approach in Machado-Joseph d
270  brain cell types, may be able to unlock the neuroprotective therapeutic potential of idebenone or re
271 cological inhibition of PFKFB3 is a suitable neuroprotective therapeutic strategy in excitotoxic-rela
272  Abeta-mediated oxidative stress, supporting neuroprotective therapies aimed at ameliorating defects
273       These data open the possibility of new neuroprotective therapies aimed at SPN synapse function,
274 t challenges in the development of potential neuroprotective therapies has been the lack of reliable
275                                     Although neuroprotective therapies have been suggested to have th
276 d death worldwide, yet there are no approved neuroprotective therapies that improve neurological outc
277 rogression, there is an unmet need for novel neuroprotective therapies to support RGC survival.
278 fficacy of new treatments; however, previous neuroprotective therapies, based on systemic delivery in
279 t to intervene for the purpose of evaluating neuroprotective therapies.
280 dria will therefore be central to developing neuroprotective therapies.
281 eta2 may represent a target for prophylactic neuroprotective therapy in populations at high risk of s
282 ative states, and potentially intervene with neuroprotective therapy.
283            We next found that astrocytes are neuroprotective to seeded aggregation within motor neuro
284 ggest a previously unknown mechanism for the neuroprotective traits of widely used preventive therape
285 nAChR) in fetal microglia will augment their neuroprotective transcriptome profile, while the antagon
286  describe a clinically translatable topical, neuroprotective treatment (recombinant human nerve growt
287         Together, our results suggest that a neuroprotective treatment based on the enhancement of th
288 rapidly translatable, disease-modifying, and neuroprotective treatment for Friedreich's ataxia.
289 sue to identify a subset of patients in whom neuroprotective treatment might be of benefit.
290 , thus constituting a promising agent for HD neuroprotective treatment.
291 human immunodeficiency virus infection, such neuroprotective treatments could ultimately be considere
292                  However, disease-modifying, neuroprotective treatments for glaucoma remain a major u
293                          Attempts to develop neuroprotective treatments for neurodegenerative disorde
294 d GP+RAP/alpha-syn, is capable of triggering neuroprotective Treg responses in synucleinopathy models
295         Sample size estimates for definitive neuroprotective trials ranged from 142 to 366 patients p
296                                   For future neuroprotective trials, it is essential to accurately es
297 , which can be used to stratify patients for neuroprotective trials.
298 et risk reduction strategies, and administer neuroprotective trials.
299  Alzheimer's disease (AD), e4, and the major neuroprotective variant, e2.
300 ll patients and since insulin therapy may be neuroprotective, we sought to explore the association be

 
Page Top